According to a survey conducted in May 2020 in Italy, nearly 57 percent of biotech companies in the country were taking part in research and development (R&D) or production activities in the fight against the novel coronavirus disease (COVID-19). Of the 57 percent active in this effort, 44 percent were operating in the diagnostics segment, while seven percent were taking part in the race for a vaccine.
Share of biotech companies in Italy active in COVID-19 R&D as of May 2020, by product type
Loading statistic...
Basic Account
Get to know the platform
You only have access to basic statistics.
Single Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access
Corporate solution including all features.
* Prices do not include sales tax.
Further Content: You might find this interesting as well
Statistics
- YTD stock performance of biopharma companies working on COVID March 2020
- Clinical trials due to COVID-19 read out March 2020 worldwide, by stage
- Change in global biotech-pharma industry stock indices 2019
- Major biotech IPOs 2021
- Total number of biotechnology companies in Europe 2018
- Biopharmaceutical revenue - statutory health insurance market Germany 2014
- Number of pharmaceutical companies Indonesia 2018 by region
- Biotechnology companies size in Germany from 2005 to 2009 by employees
- Distribution of the pharmaceutical market Indonesia 2015 by drug type
- Changes in forward P/E ratios in the pharmaceutical industry 2015-2016
- Total value of pharma and biotech merger and acquisition deals 2015-2021
- COVID-19 impact on investment plans in Russia 2020, by size
- Opinion of assurance on helping those affected from COVID-19 Philippines 2019
- Paraguay: pharmaceutical products export value 2014-2019
Assobiotec. (May 28, 2020). Share of biotech companies in Italy active in COVID-19 R&D as of May 2020, by product type [Graph]. In Statista. Retrieved July 06, 2022, from https://www.statista.com/statistics/1181958/biotech-firms-active-in-research-or-production-against-covid-19-in-italy-by-field/
Assobiotec. "Share of biotech companies in Italy active in COVID-19 R&D as of May 2020, by product type." Chart. May 28, 2020. Statista. Accessed July 06, 2022. https://www.statista.com/statistics/1181958/biotech-firms-active-in-research-or-production-against-covid-19-in-italy-by-field/
Assobiotec. (2020). Share of biotech companies in Italy active in COVID-19 R&D as of May 2020, by product type. Statista. Statista Inc.. Accessed: July 06, 2022. https://www.statista.com/statistics/1181958/biotech-firms-active-in-research-or-production-against-covid-19-in-italy-by-field/
Assobiotec. "Share of Biotech Companies in Italy Active in Covid-19 R&d as of May 2020, by Product Type." Statista, Statista Inc., 28 May 2020, https://www.statista.com/statistics/1181958/biotech-firms-active-in-research-or-production-against-covid-19-in-italy-by-field/
Assobiotec, Share of biotech companies in Italy active in COVID-19 R&D as of May 2020, by product type Statista, https://www.statista.com/statistics/1181958/biotech-firms-active-in-research-or-production-against-covid-19-in-italy-by-field/ (last visited July 06, 2022)